The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort

[1]  Isabelle Cournu-Rebeix,et al.  Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects , 2012, Journal of Medical Genetics.

[2]  M. Z. Cader,et al.  Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 gene , 2012, Neurology.

[3]  A. López de Munain,et al.  HLA-DRB1*15:01 and multiple sclerosis: a female association? , 2012, Multiple sclerosis.

[4]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[5]  J. Kira,et al.  Interleukin-7 receptor alpha gene polymorphism influences multiple sclerosis risk in Asians , 2011, Neurology.

[6]  D. Holtzman,et al.  Apolipoprotein E in Alzheimer's disease and other neurological disorders , 2011, The Lancet Neurology.

[7]  M. Ban,et al.  Evaluation of the established non-MHC multiple sclerosis loci in an Indian population , 2011, Multiple sclerosis.

[8]  B. Engelhardt,et al.  Differential Roles for Endothelial ICAM-1, ICAM-2, and VCAM-1 in Shear-Resistant T Cell Arrest, Polarization, and Directed Crawling on Blood–Brain Barrier Endothelium , 2010, The Journal of Immunology.

[9]  M. Ban,et al.  A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis , 2010, European Journal of Human Genetics.

[10]  A. Alcina,et al.  STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility , 2010, Genes and Immunity.

[11]  I. James,et al.  HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia , 2010, Journal of Neuroimmunology.

[12]  Ludwig Kappos,et al.  Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. , 2010, American journal of human genetics.

[13]  A. Janssens,et al.  Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis , 2009, Journal of Human Genetics.

[14]  T. Kilpatrick,et al.  Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy , 2009, Neurology.

[15]  Pablo Moscato,et al.  Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 , 2009, Nature Genetics.

[16]  T. Kilpatrick,et al.  Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus , 2009, Journal of Neuroimmunology.

[17]  Margaret A. Pericak-Vance,et al.  The role of the CD58 locus in multiple sclerosis , 2009, Proceedings of the National Academy of Sciences.

[18]  James Wason,et al.  Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor , 2009, European Journal of Human Genetics.

[19]  Michael R. Johnson,et al.  Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. , 2009, Human molecular genetics.

[20]  T. Speed,et al.  Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians , 2008, Genes and Immunity.

[21]  Hanne F. Harbo,et al.  Refining genetic associations in multiple sclerosis , 2008, The Lancet Neurology.

[22]  Xuebin Liu,et al.  Loss of STAT3 in CD4+ T Cells Prevents Development of Experimental Autoimmune Diseases , 2008, The Journal of Immunology.

[23]  L. Peltonen,et al.  Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations , 2008, Journal of Medical Genetics.

[24]  K. Vandenbroeck,et al.  IL7RA polymorphisms and susceptibility to multiple sclerosis. , 2008, The New England journal of medicine.

[25]  Silke Schmidt,et al.  Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis , 2007, Nature Genetics.

[26]  H. Harbo,et al.  Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis , 2007, Nature Genetics.

[27]  S. Gabriel,et al.  Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.

[28]  J. Haines,et al.  APOE epsilon variation in multiple sclerosis susceptibility and disease severity , 2006, Neurology.

[29]  F. Svensson,et al.  Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis , 2005, Genes and Immunity.

[30]  E. Génin,et al.  Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosis , 2003, Genes and Immunity.

[31]  J. Ilonen,et al.  Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis. , 2003, Human immunology.

[32]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[33]  G. Le Gros,et al.  The role of CTLA‐4 in the regulation of T cell immune responses , 1999, Immunology and cell biology.

[34]  K. Selmaj,et al.  Multiple sclerosis: The increased frequency of the ICAM‐1 exon 6 gene point mutation genetic type K469 , 1998, Annals of neurology.

[35]  G. Stein,et al.  Interferon regulatory factors: growth control and histone gene regulation – it’s not just interferon anymore , 1997, Journal of Molecular Medicine.

[36]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[37]  J. Haines,et al.  The expanding genetic overlap between multiple sclerosis and type I diabetes , 2009, Genes and Immunity.

[38]  L. Mucke,et al.  Apolipoprotein E , 2007, Journal of Molecular Neuroscience.

[39]  F. Christiansen,et al.  HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. , 2001, Tissue antigens.